Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics

NEXT STORY
Myriad Announces New Studies Validating the Ability of Myriad’s riskScore® Test to Modify Breast Cancer Risk Prediction
PREV STORY
Reata Announces Promotion and New Hires For Key Leadership Roles
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.

SHANGHAI, China and CUPERTINO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group ...

author_avatar
NASDAQ Market News

Athenex to Present at Deutsche Bank’s 43rd Annual Health Care Conference

BUFFALO, N.Y., May 08, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

author_avatar
NASDAQ Market News

The Expanding Role of AMH as a Predictor of Fertility

SALT LAKE CITY, Sept. 2, 2015 (GLOBE NEWSWIRE) -- While slowing down a woman's ...

author_avatar
NASDAQ Market News